Ledger.

Startup · $42.6m raised

AML3D

Adelaide, SA

Coverage

Stories naming AML3D. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Grant $492.5k

Best of the week — the five most popular stories among readers, July 7 – July 11, 2025

Weekly roundup of readers' five favourite stories: a hydrogen grant for 1414 Degrees, LS Precast's rail tunnel contract, AML3D's US Navy pact, quantum clock breakthrough, and Suntory Oceania's launch.

Unnamed stage $18.2m

Manufacturing news briefs – stories you might have missed

Roundup of manufacturing briefs: biotech Imugene's share plan added A$18.2 million, EVOS shifted its Brisbane head office, ANSTO won federal backing for nuclear medicine, CSIRO endowed Wollongong scholarships, plus two chief executive appointments.

4 deals

2021 additive manufacturing Aussie highlights

Year-end review of Australian additive manufacturing in 2021: MMI grants for Romar, Titomic and SPEE3D, Titomic's raises and acquisitions, Conflux's Series A, Aurora Labs' capital raise and leadership changes, and AML3D's listing anniversary.

Also @AuManufacturing·@AuManufacturing·@AuManufacturing

Unnamed stage $100m

Manufacturing news briefs – stories you might have missed

Manufacturing roundup: AML3D joins a naval shipbuilding research facility with BAE Systems and Flinders University; Cann Group recovers scam losses; Ridley divests its Westbury plant; Skedulo secures $100m from SoftBank's Vision Fund 2.

2 deals

2020 additive manufacturing Aussie highlights

Year-end review of Australian additive manufacturing covering listings by AML3D and Amaero, capital raises at several firms, GoProto's acquisitions, defence sector engagements, and the author's own 2020 activities.

Grant $1.1m

Manufacturing news briefs – stories you might have missed

Manufacturing roundup: DevelopmentWA seeks robotics precinct partners, AML3D completes a 3D-printed propeller, Bionomics licenses CAR-T to Carina Biotech, and University of Sydney wins a grant supporting Vaxxas vaccine-patch research.

Something wrong? Tell us